N
TECX

Nuveen’s Tectonic Therapeutic TECX Stock Holding History

Nuveen’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$372K Sell
12,033
-2,271
-16% -$55.9K ﹤0.01% 2945
2025
Q4 		$298K Hold
14,304
– – ﹤0.01% 3047
2025
Q3 		$224K Hold
14,304
– – ﹤0.01% 3128
2025
Q2 		$284K Buy
+14,304
New +$290K ﹤0.01% 3079
2022
Q2 		– Sell
-11,492
Closed -$218K – 3518
2022
Q1 		$218K Buy
11,492
+315
+3% +$6.51K ﹤0.01% 3175
2021
Q4 		$440K Sell
11,177
-3,073
-22% -$177K ﹤0.01% 3104
2021
Q3 		$1.06M Buy
14,250
+220
+2% +$18.1K ﹤0.01% 2973
2021
Q2 		$1.5M Buy
14,030
+2,876
+26% +$341K ﹤0.01% 2838
2021
Q1 		$1.7M Sell
11,154
-1,274
-10% -$207K ﹤0.01% 2693
2020
Q4 		$2.08M Buy
12,428
+450
+4% +$80K ﹤0.01% 2494
2020
Q3 		$1.87M Buy
11,978
+143
+1% +$28.8K ﹤0.01% 2418
2020
Q2 		$2.48M Buy
11,835
+2
+0% +$412 ﹤0.01% 2248
2020
Q1 		$2.21M Buy
11,833
+74
+0.6% +$17.4K ﹤0.01% 2139
2019
Q4 		$2.84M Sell
11,759
-1,584
-12% -$305K ﹤0.01% 2271
2019
Q3 		$2.26M Buy
13,343
+7,943
+147% +$1.8M ﹤0.01% 2347
2019
Q2 		$1.05M Buy
+5,400
New +$1.16M ﹤0.01% 2712

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Nuveen's TECX Position: Q1 2026 in Review

Nuveen reduced its Tectonic Therapeutic (TECX) stake by 16% in Q1 2026, selling an estimated $55.9K and leaving 12,033 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #2945.

Nuveen first reported a position in TECX in Q2 2019 and has held it in 16 quarters since. The position peaked at $2.84M in Q4 2019. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Nuveen held 12,033 shares of Tectonic Therapeutic worth $372K as of Q1 2026.
  • Nuveen sold 2,271 Tectonic Therapeutic shares in Q1 2026, an estimated $55.9K.
  • Tectonic Therapeutic made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2945 holding.
  • Nuveen first reported a position in Tectonic Therapeutic in Q2 2019 and has held it in 16 quarters since.
  • Nuveen's Tectonic Therapeutic position peaked at $2.84M in Q4 2019.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.